ABSTRACT: This study was undertaken to investigate the prevalence of sequence variants in LCA5 in patients with Leber congenital amaurosis (LCA), early-onset retinal dystrophy (EORD), and autosomal recessive retinitis pigmentosa (arRP); to delineate the ocular phenotypes; and to provide an overview of all published LCA5 variants in an online database. Patients underwent standard ophthalmic evaluations after providing informed consent. In selected patients, optical coherence tomography (OCT) and fundus autofluorescence imaging were possible. DNA samples from 797 unrelated patients with LCA and 211 with the various types of retinitis pigmentosa (RP) were screened by Sanger sequence analysis of all LCA5 exons and intron/exon junctions. Some LCA patients were pre- 
Introduction
Leber congenital amaurosis (LCA) is an infantile onset, severe retinal dystrophy that presents with profound visual impairment, inability to fixate and nystagmus from birth or within the first few weeks of life [von Leber, 1869] . It is the most severe form of a spectrum of disorders arising within the first few years of life, which affect both rod and cone photoreceptors, termed childhood or earlyonset retinal dystrophy (EORD) [Gu et al., 1997] . The term juvenile retinitis pigmentosa (RP) has also been used to describe EORD. Autosomal recessive RP (arRP) falls into this spectrum of disorders with onset typically later in childhood or beyond. LCA accounts for 3%-5% of childhood blindness in the developed world and has an incidence of two to three per 100,000 live births [Heckenlively et al., 1988] . Depending on the age at diagnosis, the retinal appearance may be normal or there may be a variety of abnormalities including vascular narrowing, macular atrophy, peripheral white dots at the level of the retinal pigment epithelium (RPE), and retinal pigmentation. The full-field electroretinogram (ERG) is usually nondetectable (<10 μV) with conventional ERG testing or severely decreased before the age of 1 year [Foxman et al., 1985; Franceschetti and Dieterle, 1954] .
LCA is predominantly inherited as an autosomal recessive trait, although rare dominant forms have been reported [Swaroop et al., 1999] . Nineteen causative genes have thus far been reported: AIPL1 [MIM #604392] [Sohocki et al., 2000] , CABP4 [MIM #608965] [Aldahmesh et al., 2010] Hollander et al., 2001] , CRX [MIM #602225] [Freund et al., 1998 ], GUCY2D [MIM #600179] [Perrault et al., 1996] Hollander et al., 2007] , LRAT [MIM #604863] [ Thompson et al., 2001] , MERTK [MIM #604705] [Gal et al., 2000] , NMNAT1 [MIM #608700] [Chiang et al., 2012; Falk et al., 2012; Koenekoop et al., 2012; Perrault et al., 2012] , RD3 [MIM #180040] [Friedman et al., 2006] , RDH12 [MIM #608830] [Janecke et al., 2004] , RPGRIP1 [MIM #605446] [Dryja et al., 2001] , RPE65 [MIM #180069] [Gu et al., 1997; Marlhens et al., 1997] , SPATA7 [MIM #609868] [Wang et al., 2009] , and TULP1 [MIM #602280] [Hanein et al., 2004] . Interestingly, mutations in some of these genes, such as CEP290 [Littink et al., 2010] , CRB1 [den Hollander et al., 1999] , LRAT [Thompson et al., 2001] , MERTK [Gal et al., 2000] , RPE65 [Morimura et al., 1998 ], and SPATA7 [Wang et al., 2009] , may also be associated with milder forms of retinal dystrophy.
The LCA5 locus (MIM #604537) was mapped to chromosome 6q11-q16 by traditional linkage studies in a multigenerational kindred of the Old Order River Brethren [Dharmaraj et al., 2000] . Further homozygosity mapping in consanguineous and nonconsanguineous families led to a refinement of the critical region [den Hollander et al., 2007; Mohamed et al., 2003 ] and the causative gene, LCA5, was identified [den Hollander et al., 2007] . LCA5 comprises nine exons, seven of which encode Lebercilin, a 697 amino acid protein that contains four coiled-coil domains [den Hollander et al., 2007] . Lebercilin is widely expressed in human tissues including cilia. In situ hybridization of mouse embryos at day 12.5 postcoitum detected almost ubiquitous, low-level staining. At embryonic day 14.5, staining of the eye, inner ear, kidney, and regions of the central and peripheral neural system, gut and the ciliated epithelium of the nasopharynx, trachea, and lungs was more pronounced. In the adult eye, expression was limited to the photoreceptor cell layer. In ciliated cell lines, lebercilin localizes to the ciliary axoneme. In mouse and rat retina, it is found between the outer and inner segments of the photoreceptor layer. In a human embryonic kidney cell line, HEK293, recombinant lebercilin was found to interact with 24 proteins, many of which are associated with centrosomal or ciliary functions, and the intraflagellar transport machinery [Boldt et al., 2011] . Lca5 inactivation in mice led to very severe and rapid retinal degeneration. At 1 month postnatally, there was a significant reduction in photoreceptor cells, and after 4 months, the photoreceptor layer was completely absent [Boldt et al., 2011] .
To date, 12 different mutations in LCA5 have been reported. In patients of all families except one, the phenotype has been typical of LCA [Abu-Safieh et al., 2013; Ahmad et al., 2011; den Hollander et al., 2007; Gerber et al., 2007; Jacobson et al., 2009; Li et al., 2011; Ramprasad et al., 2008; Vallespin et al., 2010a; Vallespin et al., 2010b] . Despite its ubiquitous expression and its crucial functions in the cilia [Boldt et al., 2011] , the phenotype associated with LCA5 mutations has thus far been confined to the retina. In this paper, we present the results of screening for mutations in LCA5 in a large number of subjects with LCA and EORD (n = 797), and arRP (n = 211), and describe the associated phenotypes.
Materials and Methods

Patients
In total, we sequenced 1,008 patients. We ascertained 797 probands with LCA and EORD, living in Belgium (n = 47), Canada and the USA (n = 300), Germany (n = 65), The Netherlands (n = 54), South Africa (n = 18), Sweden (n = 20), Switzerland (n = 42), China (n = 100), Pakistan (n = 1), and the United Kingdom (n = 150). In addition, we included 211 persons with isolated or arRP from The Netherlands. Many LCA and arRP patients were not originally from their current place of residence and were actually from India, Pakistan, Russia, and other countries. Approximately 50% of the persons with LCA were previously analyzed using various Asper Ophthalmics LCA allele-specific primer extension (APEX) mutation chips. None of the DNAs of persons with arRP were previously analyzed for LCA5 mutations using APEX. LCA, EORD, and RP may be considered a continuum of retinal dystrophies, in which LCA represents the extreme end of severity, as far as the age of onset and functional outcome are concerned. In our current study, LCA was diagnosed in children who were born with severe visual loss, inability to fixate at around 6 weeks of age, nystagmus, and absent or nondetectable ERGs. EORD was diagnosed in children born with reduced, but clinically identifiable, visual function and fixation, with or without nystagmus, and with progressive night blindness and subsequent vision loss. arRP was diagnosed in patients without nystagmus, a variable onset of progressive night blindness and visual loss after the age of 2 years.
Clinical Investigations
All patients and family members provided informed consent as part of research projects approved by the local research ethics committees, and the study was conducted in accordance with the principles of the Declaration of Helsinki. Clinical evaluation, including monocular best-corrected visual acuity by projected Snellen charts, slit-lamp biomicroscopy, and fundus examination was performed on all patients who could cooperate with testing. Where possible, patients underwent retinal imaging using a Topcon TRC 501A retinal camera (Topcon Corporation, Tokyo, Japan), optical coherence tomography using a SPECTRALIS R Spectral domain optical coherence tomography (OCT) scanner (Heidelberg Engineering, Heidelberg, Germany), and retinal autofluorescence imaging using a confocal scanning laser ophthalmoscope (Zeiss Prototype; Carl Zeiss Inc., Oberkochen, Germany). Pattern and full-field electroretinogram (PERG and ERG) were performed, where possible, using the recommendations of the International Society for Clinical Electrophysiology of Vision (ISCEV) or a modified Paediatric ERG protocol with skin electrodes as previously described [Flitcroft et al., 2005; Kriss, 1994; Marmor et al., 2009] . Patient #14 (Berman-Gund Laboratory ID: 048-038) was evaluated by full-field ERG testing using Burian Allen contact lens electrodes, narrow band-passed filtering, and computer averaging that can extend the range of detectability of 30 Hz cone ERGs to 0.05 μV [Berson et al., 1993] . Goldmann perimetry was performed in patient #16.
Blood samples were collected in EDTA tubes and DNA was extracted using the Puregene blood extraction kit (Invitrogen, Paisley, UK) following manufacturer's instructions, or by a standard salting out procedure [Miller et al., 1988] .
Mutation Screening
Nucleotide numbering reflects cDNA with +1 corresponding to the A of the ATG translation initiation codon (RefSeq NM 181714.3), according to journal guidelines (www.hgvs.org/ mutnomen). The initiation codon is codon 1. Primers used to amplify the coding exons and the intron-exon boundaries of LCA5 were designed using those published previously [den Hollander et al., 2007] . In addition, 194 persons with LCA and 94 persons with arRP were analyzed for the presence of an exon 1 deletion identified in the original LCA5 family [den Hollander et al., 2007] . To this end, primers 5 -TTCCGTGCAATTTAGGGATT-3 and 5 -CGGGGTTTTTGTTTTGTTTG-3 were designed to amplify a deletion breakpoint fragment of 117 bp. All standard polymerase chain reactions (PCR) were performed in a total volume of 30 μl containing 200 μM dNTPs (Bioline, London, UK), 20 μM of each primer, 1× reaction buffer with 1.5 mM MgCl 2 (Bioline) with 1 unit of Biotaq (Bioline) and 100 ng of DNA. PCR was carried out on a PTC200 DNA engine thermal cycler (Bio-Rad, Hemel Hempstead, UK). Cycling conditions were as follows: 5 min denaturation at 94
• C followed by 35 cycles of 94
• C for 30 sec, annealing temperature for 30 sec, and extension at 72
• C for 30 sec. A final extension of 72
• C for 5 min completed the cycling conditions. PCR products were visualized on a 2% agarose gel containing 0.05% ethidium bromide. The products were cleaned using multiscreen PCR filter plates (Millipore, Watford, UK) prior to sequencing. PCR products were sequenced directly using the ABI Prism Big Dye terminator Kit (V3.1, Applied Biosystems, Foster City, CA) in a 10-μl reaction. Samples were purified using the Montage cleanup kit (Millipore) prior to being run on an ABI applied biosystems 3730 DNA sequencer (Applied Biosystems). Electropherograms were analyzed for sequence changes using DNAStar computational software (DNAStar, Inc., Madison, WI). Any sequence changes identified were checked visually.
Mutations were tested in normal controls when possible, and cosegregation was performed in the families, when possible. Mutation frequencies were analyzed in the exome variant server database, 1000 genomes database, and dbSNP database. In silico analyses were then performed to assess pathogenicity, including Blosum62, Polyphen2, and PhyloP.
Patient #1 was originally identified to harbor a heterozygous mutation in LCA5 by microarray analysis using the Asper LCA Apex chip. His second mutation was identified following LCA5 sequence analysis. Patient #18 was selected for LCA5 sequence analysis because homozygosity mapping of two affected persons (IV:2 and IV:3) of family W12-2240 ( Fig. 1) showed a large, significant homozygous region surrounding LCA5. To identify this region, we had employed the CytoScan R High-Density array containing probes to detect 750,000 single-nucleotide polymorphisms (Affymetrix, Santa Clara, CA).
Results
Mutational Analysis
A total of 797 patients with LCA and EORD and 211 with arRP were screened for sequence variants in protein-coding exons (i.e., exons 3 through 9) of LCA5. Sixteen probands were identified with two disease-causing variants. In all, 19 different LCA5 variants were identified (Table 1) ; 17 of these variants are novel. Homozygous variants were found in 10 probands, compound heterozygous variants in six probands, and heterozygous protein truncating variants in two probands (Table 1) .
All but two mutations were predicted to lead to premature termination of the lebercilin protein. One of the missense mutations that we identified was in patient #4 involving the first amino acid of the lebercilin protein (p.Met1Ile). The other missense change is a novel change in patient #16 involving a histidine to arginine change at position 164 (p.His164Arg). The underlying c.491A>G variant was not found in 8,600 alleles of "control" individuals in the Exome Variant Server database and once in the 1000 genomes database (rs183669161). Unfortunately, we do not have parental DNA to test for segregation. The PhyloP score of c.491A is 3.92, Polyphen2 predicts damage, and the histidine at position 164 is fully conserved between human, rhesus, mouse, dog, opossum, chicken, Western clawed frog, and zebrafish. In an affected half-brother (IV:1) and an affected cousin (V:1) of patient #7 (Fig. 1A) , the same homozygous splice site variant (c.1231+2insT) was found, and two unaffected persons carried this variant in the heterozygous state. This variant is predicted to completely inactivate this splice site based on SpliceSiteFinder, MaxEntSplice, and NNSplice analysis. Homozygosity mapping using DNA from two persons with LCA from family W12-2240 (Fig. 1B: patients IV:2 and IV:3) yielded 10 shared homozygous regions larger than 5 Mb. The third largest homozygous region on chromosome 6 (18.9 Mb) encompassed LCA5. In all three affected individuals (Fig. 1B) , the c.1151delC (p.Pro384Glnfs * 18) variant was identified in the homozygous state in LCA5. This variant was present in the heterozygous state in five unaffected members (Fig. 1B) . The ethnic origins of the 18 probands with LCA5 mutations were as follows: European Caucasian: 7 (British, Slovakian-Romani, and Spanish); Asian: 7 (Pakistan, Afghanistan, Indian-Mauritian, Iraqi, Taiwanese, and Chinese); North American: 3; Mexican: 1.
Clinical Phenotype
Of the 18 probands with LCA5 variants identified in this study, all but two patients had a clinical diagnosis of LCA, with onset of severe visual loss at birth or within the first few months of life, and nystagmus (Table 2) . However, patients #7 and #16 received a diagnosis of EORD. Patient #7 was born with congenital nystagmus, and developed night blindness at the age of 3, visual field loss at the age of 6, and visual loss at the age of 8. In patient #16, the visual loss started after the age of 40 years. In addition, patient #16 did not have nystagmus. All of our LCA and EORD patients had nyctalopia and severe visual field constriction. General health was good in the majority of patients, except in patient #2 who had global developmental delay and patient #3 who had behavioral problems. Fourteen of the 16 LCA patients were legally blind with visual acuity ranging from 1.0 logMAR to light perception. One patient, #11, with LCA and nystagmus, had visual acuities of 0.48 right (20/60) and 0.54 left (20/70) at the age of 6 years ( Table 2) . Patient #16, with EORD, had a visual acuity of 0.30 (20/40) at the age of 55 years. Most patients had a hypermetropic refraction ( Table 2 ). The high myopic correction in patient #6 may be attributed to keratoconus. A fullfield ERG was performed in eight patients and was nondetectable (<10 μV) with conventional ERG testing in five patients. A small cone ERG response could be quantified in patient #14 and trace cone ERG responses (unquantified) could be detected in patient #16 (Table 2) . Anterior segments were normal in all but one of the oldest patients (patient #6), who had bilateral keratoconus at the age of 37 years. This patient also developed bilateral nuclear sclerotic and posterior subcapsular lenticular opacities in adulthood.
Fundus examination most commonly revealed widespread retinal pigment epithelial atrophy and granularity, with peculiar, small, white dots at the level of the RPE in the retinal periphery, which were seen in 10 of 14 patients (71%) in whom funduscopic data were available (Fig. 2) . Figure 2B and C shows the white dots clearly, and document the round, evenly spaced, similar-sized lesions. Intraretinal pigment migration, when present, was minimal, situated in the far retinal periphery, and seen in the oldest patients, patients #1, #6, #7, #14, and #16 ( Fig. 2A, D , and E). Macular atrophy was noted in only three patients, #3, #16, and #17 (Fig. 2B , E, and F); the macula was otherwise normal on funduscopy in the remaining patients. In one patient, the macular lesion was particularly severe, with features of a "macular coloboma" (Fig. 2F) . Optic discs were normal in appearance (pink disc color) in all but one patient (patient #14), who had optic disc drusen (Fig. 2D) . In one family with arRP (patient #7), we identified a pumpkin-colored maculopathy and intraretinal pigmentation in the periphery with faintly preserved islands of RPE (Fig. 3) . OCT data, available for patients #1, #11, and #16, showed preservation of the central foveal inner segment/outer segment (IS/OS) junctions and of the outer segments in the two younger patients (#1 and #11) (Fig. 4A and B) . In the older patient (#16), OCT imaging demonstrated macular atrophy, disruption of retinal lamination, and the presence of a hyporeflective well-circumscribed area in the outer nuclear layer, with a hyperreflective border. This may There is widespread RPE atrophy, peripheral preserved islands of RPE (white arrow), peripheral intraretinal pigmentation, and a "pumpkin"-colored macula.
represent an area of outer retinal tubulation (also known as rosettes) (Fig. 4C) . OCT image acquisition was otherwise not possible due to nystagmus. Fundus autofluorescence (FAF) imaging data were available in two patients (Fig. 5) . FAF in patient #1 revealed an overall hypofluorescence in the macula, with a central hyperfluorescent signal in the fovea (Fig. 5A) . FAF images of patient #16 showed severe hypofluorescence in the macula corresponding to significant RPE atrophy (Fig. 5B) . Goldmann perimetry in patient #16 revealed a small central island, with a relatively large preserved nasal field and a small temporal field.
Discussion
LCA5 mutations are a rare cause of LCA. Previously, only 12 different mutations had been identified and published in 16 families with LCA. In the current study, which is the largest study to date, we have screened the coding region of LCA5 in 1,008 patients, 797 with LCA and EORD, and 211 with arRP, ascertained from eight different countries. We identified mutations in 18 new LCA families. We discovered 19 different LCA5 mutations, 17 of which are novel. Mutations in LCA5 thus account for ∼2% of patients with LCA, EORD, and arRP in our cohort. All 29 different LCA5 variants have now been included in the new Leiden Open Variation Database (LOVD; http://www.LOVD.nl/LCA5). In two patients (#14 and #15), we identified heterozygous variants. The second allele may have been missed because the variant may be located outside the protein-coding exons, or because these variants are causative in a more complex inheritance model (such as digenic), or that these are coincidental findings of heterozygous variants that play no role in the LCA phenotype.
The majority of LCA5 mutations found both in this study and in those published previously are likely null mutations due to premature termination of the protein. Only one missense mutation in this gene (p.Ser202Pro) has been previously reported in LCA, but without accompanying clinical information [Vallespin et al., 2010b] . We also identified a missense variant, p.Met1Ile (the start codon), in patient #4, who carried a diagnosis of LCA, in combination with the most common LCA5 stop mutation p.Gln279
* . If the next methionine in the open reading frame were to be used instead (at position 336), as the alternative start codon, then two coiled-coiled domains in the lebercilin protein would be lacking, very likely rendering the truncated lebercilin inactive. Therefore, this missense mutation may also be a null allele. We also identified another missense mutation, p.His164Arg. This mutation was found in combination with a novel nonsense mutation, p.Tyr23 * , in LCA patient #16, but segregation data are lacking. Thus, we cannot exclude that these variants are in cis configuration and that they are not causative for the phenotype in patient #16.
Previously, and in the majority of patients in this study, the phenotype reported in association with LCA5 mutations is consistent with LCA with severely reduced vision at, or near birth, nystagmus, and a nondetectable (<10 μV) ERG [Ahmad et al., 2011; den Hollander et al., 2007; Dharmaraj et al., 2000; Gerber et al., 2007; Jacobson et al., 2009; Mohamed et al., 2003; Ramprasad et al., 2008] . High hypermetropia is common. The visual acuity is reported to range between 0.20 to light perception and there is extensive peripheral field loss. In our study, the majority of patients had a clinical diagnosis of LCA, with fundus examination revealing widespread atrophy of the retina and RPE but with little intraretinal pigment migration. On the clinical examination, we commonly identified scattered white dots at the level of the RPE ( Fig. 2A-D-white arrows) . White dots can be found in other genetic types of LCA, such as RPE65, LRAT, and CEP290. In RPE65-type LCA, Weleber et al. (2011) suggested that the white dots might represent accumulations of trans-retinyl esters. The biochemical make-up of the white dots associated with LCA5 mutations is as yet unknown. Our LCA5-associated retinal phenotypes are consistent with the retinal changes observed in other patients with LCA5 mutations (Figs. 2 and 3) [Ahmad et al., 2011; Dharmaraj et al., 2000; Gerber et al., 2007; Mohamed et al., 2003; Ramprasad et al., 2008] .
However, in this study, for the first time, we identified an Iraqi family with two affected sibs who carried a diagnosis of EORD, because they maintained some useful vision until the age of 10 years. In addition, these siblings had preservation of the peripheral islands of RPE (Fig. 3) , a phenotype similar to preserved paraarteriolar retinal pigment epithelium documented by Heckenlively (1982) and later found to be associated with LCA and arRP patients with CRB1 mutations [den Hollander et al., 1999; Heckenlively, 1982] . We have thus expanded the phenotypic spectrum associated with LCA5 mutations, which now includes both EORD and a new retinal phenotype consisting of preserved islands of peripheral RPE (Fig. 3) .
There is little published data on retinal imaging such as OCT and FAF imaging in patients with LCA5 mutations. In this regard, we here contribute three new patients with LCA5 mutations and new OCT and FAF data. However, it is a limitation of the present study that we were unable to obtain good quality autofluorescence imaging and OCT on the entire cohort. This was, in part, due to the inherent difficulties of such imaging in patients with nystagmus, their ages and their remote living conditions. Jacobson et al. (2009) reported a low autofluorescent signal corresponding to macular atrophy in two siblings with a homozygous LCA5 mutation, in whom mutations in CRB1 had previously been excluded. We demonstrated similar macular hypoautofluorescence in one subject who in addition had a small area of hyperautofluorescence at the fovea, suggesting continued metabolic activity of the foveal cones and RPE. In our study, OCT imaging was possible in three subjects, and the findings revealed surprising preservation of the central foveal IS/OS junctions and of the outer segment structures (in the younger patients, of the age of 17 years and 6 years, respectively). In the older patient, of the age of 55 years, OCT imaging demonstrated macular atrophy, loss of the retinal lamination, and probable outer retinal tubulation (also known as rosettes), a late-stage process in the degeneration of photoreceptors that has been described recently in a number of retinal conditions (Fig. 4C) [Sergouniotis et al., 2012; Zweifel et al., 2009] . Previously published OCT findings have demonstrated loss of the photoreceptor and outer nuclear layers, and abnormal retinal lamination eccentric to the fovea, but with evidence of a retained photoreceptor layer at the fovea [Jacobson et al., 2009] . This suggests that in the early stages of the disease, there may be viable photoreceptors (cones) in the foveal region, which may be amenable to therapeutic intervention. It is of interest that patient #14 at the of age of 19, with an advanced stage of disease, still had a detectable 30 Hz cone ERG in each eye (Table 2) with narrow band-passed filtering and computer averaging. In future clinical trials, this technique of ERG recording, which is not performed in the present ISCEV protocol, could be considered as a method of objectively monitoring efficacy or lack of efficacy as undoubtedly most patients with remaining vision will have a detectable cone ERG with this technique.
Lebercilin is expressed in a number of tissues; however, there have been no reports of extraocular abnormalities in LCA5 mutations. One patient with LCA5 retinopathy died from asphyxia and the authors propose a possible link between the cause of death and the presence of lebercilin in the bronchial ciliated epithelial cells [Ramprasad et al., 2008] . In the present study, one patient had global developmental delay, whereas another experienced behavioral problems. Whether this is related to abnormal extraocular expression of lebercilin remains to be determined.
LCA5-associated LCA is a rare form of severe childhood onset retinal dystrophy. Most LCA5 mutations are null and are associated with a severe phenotype. Missense mutations are rare and may be associated with a milder EORD, suggesting that such mutations may result in some residual protein function. LCA5-type LCA may be amenable to treatment, but this is more likely to be successful in young patients.
